Suppr超能文献

非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学

Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

作者信息

Takahashi Yoshihisa, Fukusato Toshio

机构信息

Yoshihisa Takahashi, Toshio Fukusato, Department of Pathology, Teikyo University School of Medicine, Tokyo 173-8605, Japan.

出版信息

World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.

Abstract

Nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of metabolic syndrome, is the most common chronic liver disease, and the prevalence is rapidly increasing worldwide. Nonalcoholic steatohepatitis (NASH), the severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma (HCC). Although noninvasive clinical scores and image-based diagnosis for NAFLD have improved, histopathological evaluation of biopsy specimens remains the gold standard for diagnosing NAFLD/NASH. Steatosis, lobular inflammation, and hepatocellular ballooning are all necessary components for the diagnosis of NASH; fibrosis is also typically observed. Other histopathological abnormalities commonly observed in NASH include hepatocellular glycogenated nuclei, lipogranulomas, and acidophil bodies. The characteristics of pediatric NAFLD/NASH differ from adult NAFLD/NASH. Specifically, steatosis and portal inflammation are more severe in pediatric NAFLD, while intralobular inflammation and perisinusoidal fibrosis are milder. Although interobserver agreement for evaluating the extent of steatosis and fibrosis is high, agreement is low for intralobular and portal inflammation. A recently reported histological variant of HCC, steatohepatitic HCC (SH-HCC), shows features that resemble non-neoplastic steatohepatitis, and is thought to be strongly associated with underlying NASH. In this report, we review the histopathological features of NAFLD/NASH.

摘要

非酒精性脂肪性肝病(NAFLD)是代谢综合征的肝脏表现,是最常见的慢性肝病,在全球范围内患病率正在迅速上升。非酒精性脂肪性肝炎(NASH)是NAFLD的严重形式,可进展为肝硬化和肝细胞癌(HCC)。尽管NAFLD的非侵入性临床评分和基于图像的诊断方法有所改进,但活检标本的组织病理学评估仍然是诊断NAFLD/NASH的金标准。脂肪变性、小叶炎症和肝细胞气球样变都是诊断NASH的必要组成部分;通常也会观察到纤维化。NASH中常见的其他组织病理学异常包括肝细胞糖原核、脂肪肉芽肿和嗜酸性小体。儿童NAFLD/NASH的特征与成人NAFLD/NASH不同。具体而言,儿童NAFLD中的脂肪变性和门管区炎症更严重,而小叶内炎症和窦周纤维化较轻。尽管观察者之间对评估脂肪变性和纤维化程度的一致性较高,但对小叶内和门管区炎症的一致性较低。最近报道的一种HCC组织学变体,脂肪性肝炎相关性HCC(SH-HCC),表现出类似于非肿瘤性脂肪性肝炎的特征,并且被认为与潜在的NASH密切相关。在本报告中,我们回顾了NAFLD/NASH的组织病理学特征。

相似文献

1
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
3
Clinical relevance of liver histopathology and different histological classifications of NASH in adults.
Expert Rev Gastroenterol Hepatol. 2018 Apr;12(4):351-367. doi: 10.1080/17474124.2018.1415756. Epub 2017 Dec 26.
5
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
World J Gastroenterol. 2019 Mar 21;25(11):1307-1326. doi: 10.3748/wjg.v25.i11.1307.
6
Role of liver biopsy in nonalcoholic fatty liver disease.
World J Gastroenterol. 2014 Jul 21;20(27):9026-37. doi: 10.3748/wjg.v20.i27.9026.
7
8
Pathological features of fatty liver disease.
Gastroenterology. 2014 Oct;147(4):754-64. doi: 10.1053/j.gastro.2014.07.056. Epub 2014 Aug 7.
10
Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH).
Methods Mol Biol. 2022;2455:1-18. doi: 10.1007/978-1-0716-2128-8_1.

引用本文的文献

1
Critical Role of Cholic Acid in the Development of iHFC Diet-induced MASH in TSNO Mice.
Inflammation. 2025 Jun 9. doi: 10.1007/s10753-025-02294-5.
2
Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma.
JHEP Rep. 2025 Feb 14;7(5):101354. doi: 10.1016/j.jhepr.2025.101354. eCollection 2025 May.
7
Study of Ovarian Damage in Piglets in an Experimental Model of Neonatal Asphyxia.
Children (Basel). 2025 Mar 17;12(3):371. doi: 10.3390/children12030371.
10
Evaluation of Controlled Attenuation Parameter as a Tool for Assessment of Hepatic Steatosis in Living Liver Donors.
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102514. doi: 10.1016/j.jceh.2025.102514. Epub 2025 Feb 12.

本文引用的文献

2
Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis.
Proteomics Clin Appl. 2013 Oct;7(9-10):648-56. doi: 10.1002/prca.201200137. Epub 2013 Sep 17.
5
Nonalcoholic fatty liver disease: what the pathologist can tell the clinician.
Dig Dis. 2012;30 Suppl 1:61-8. doi: 10.1159/000341127. Epub 2012 Oct 11.
7
Histopathological characteristics of non-alcoholic fatty liver disease in children: Comparison with adult cases.
Hepatol Res. 2011 Nov;41(11):1066-74. doi: 10.1111/j.1872-034X.2011.00855.x.
8
The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis.
Hum Pathol. 2012 May;43(5):737-46. doi: 10.1016/j.humpath.2011.07.005. Epub 2011 Oct 20.
9
Centrizonal arteries and microvessels in nonalcoholic steatohepatitis.
Am J Surg Pathol. 2011 Sep;35(9):1400-4. doi: 10.1097/PAS.0b013e3182254283.
10
Human fatty liver disease: old questions and new insights.
Science. 2011 Jun 24;332(6037):1519-23. doi: 10.1126/science.1204265.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验